Literature DB >> 28763513

Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.

Honami Takada, Ken-Ichi Imadome, Haruna Shibayama, Mayumi Yoshimori, Ludan Wang, Yasunori Saitoh, Shin Uota, Shoji Yamaoka, Takatoshi Koyama, Norio Shimizu, Kouhei Yamamoto, Shigeyoshi Fujiwara, Osamu Miura, Ayako Arai.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0174136.].

Entities:  

Year:  2017        PMID： 28763513      PMCID： PMC5538658          DOI： 10.1371/journal.pone.0182682

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


There is an error in affiliation 4 for Yasunori Saitoh, Shin Uota, and Shoji Yamaoka. Affiliation 4 should be: Department of Molecular Virology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Bunkyo-ku, Tokyo, Japan.
  1 in total

1.  EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.

Authors:  Honami Takada; Ken-Ichi Imadome; Haruna Shibayama; Mayumi Yoshimori; Ludan Wang; Yasunori Saitoh; Shin Uota; Shoji Yamaoka; Takatoshi Koyama; Norio Shimizu; Kouhei Yamamoto; Shigeyoshi Fujiwara; Osamu Miura; Ayako Arai
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240
  1 in total
  1 in total

1.  Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection.

Authors:  Mayumi Yoshimori; Haruna Shibayama; Ken-Ichi Imadome; Fuyuko Kawano; Ayaka Ohashi; Miwako Nishio; Norio Shimizu; Morito Kurata; Shigeyoshi Fujiwara; Ayako Arai
Journal:  Blood Adv       Date:  2021-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.